Axogen (AXGN) Total Non-Current Liabilities (2017 - 2026)
Axogen (AXGN) posted quarterly Total Non-Current Liabilities of $48.5 million for Q2 2026, down 46.8% year-over-year from $91.1 million in Q2 2025, and up 8.81% quarter-over-quarter from $44.5 million in Q1 2026.
Axogen (AXGN) Total Non-Current Liabilities (2017 - 2026) Analysis & Trends
Axogen's Total Non-Current Liabilities history runs 10 years deep, the most recent figure standing at $48.5 million for Q2 2026.
- In Q2 2026, Total Non-Current Liabilities fell 46.8% year-over-year to $48.5 million; the TTM figure through Jun 2026 stood at $48.5 million (down 46.8% YoY), while the FY2025 annual figure was $89.0 million, down 8.69% from the prior year.
- Total Non-Current Liabilities for Q2 2026 stood at $48.5 million, up from $44.5 million in the prior quarter.
- The five-year high for Total Non-Current Liabilities was $98.2 million in Q4 2023, with the low at $44.5 million in Q1 2026.
- The 5-year median for Total Non-Current Liabilities is $90.0 million (2022), against an average of $86.1 million.
- The sharpest annual moves came in 2022 and 2026: Total Non-Current Liabilities grew 18.26% in 2022, then tumbled 49.53% in 2026.
- Axogen's Total Non-Current Liabilities stood at $89.9 million in 2022, then gained by 9.24% to $98.2 million in 2023, then declined by 0.77% to $97.4 million in 2024, then fell by 8.69% to $89.0 million in 2025, then slumped by 45.52% to $48.5 million in 2026.
- Business Quant data shows AXGN's Total Non-Current Liabilities at $48.5 million in Q2 2026, $44.5 million in Q1 2026, and $89.0 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 21.28 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 40.90 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 42.74 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 2.57 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 3.68 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 23.89 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 9.07 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 3.44 Bn |
| 10 | Axogen | 2.49 Bn | 2.38 Bn | 50.67 Mn | 48.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 48.47 Mn |
| Mar 31, 2026 | 44.54 Mn |
| Dec 31, 2025 | 88.95 Mn |
| Sep 30, 2025 | 93.73 Mn |
| Jun 30, 2025 | 91.10 Mn |
| Mar 31, 2025 | 88.24 Mn |
| Dec 31, 2024 | 97.42 Mn |
| Sep 30, 2024 | 90.13 Mn |
| Jun 30, 2024 | 90.79 Mn |
| Mar 31, 2024 | 90.44 Mn |
| Dec 31, 2023 | 98.18 Mn |
| Sep 30, 2023 | 92.95 Mn |
| Jun 30, 2023 | 90.22 Mn |
| Mar 31, 2023 | 87.26 Mn |
| Dec 31, 2022 | 89.87 Mn |
| Sep 30, 2022 | 89.67 Mn |
| Jun 30, 2022 | 89.52 Mn |
| Mar 31, 2022 | 88.86 Mn |
| Dec 31, 2021 | 89.91 Mn |
| Sep 30, 2021 | 90.87 Mn |